JP2024532412A - 肺疾患を処置及び予防するための組成物及び方法 - Google Patents

肺疾患を処置及び予防するための組成物及び方法 Download PDF

Info

Publication number
JP2024532412A
JP2024532412A JP2024513322A JP2024513322A JP2024532412A JP 2024532412 A JP2024532412 A JP 2024532412A JP 2024513322 A JP2024513322 A JP 2024513322A JP 2024513322 A JP2024513322 A JP 2024513322A JP 2024532412 A JP2024532412 A JP 2024532412A
Authority
JP
Japan
Prior art keywords
seq
peptide
asthma
purified peptide
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532412A5 (https=
Inventor
レッドフォード、ジュリー
クラフト、モニカ
ヴァグネル、ジョセフ
Original Assignee
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティ オブ アリゾナ
ラエセド、エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/409,642 external-priority patent/US20210379141A1/en
Application filed by アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティ オブ アリゾナ, ラエセド、エルエルシー filed Critical アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニヴァーシティ オブ アリゾナ
Priority claimed from PCT/US2022/075356 external-priority patent/WO2023028491A1/en
Publication of JP2024532412A publication Critical patent/JP2024532412A/ja
Publication of JP2024532412A5 publication Critical patent/JP2024532412A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2024513322A 2021-08-23 2022-08-23 肺疾患を処置及び予防するための組成物及び方法 Pending JP2024532412A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/409,642 2021-08-23
US17/409,642 US20210379141A1 (en) 2016-04-11 2021-08-23 Compositions and methods for treating and preventing lung disease
PCT/US2022/075356 WO2023028491A1 (en) 2021-08-23 2022-08-23 Compositions and methods for treating and preventing lung disease

Publications (2)

Publication Number Publication Date
JP2024532412A true JP2024532412A (ja) 2024-09-05
JP2024532412A5 JP2024532412A5 (https=) 2025-08-29

Family

ID=85278728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513322A Pending JP2024532412A (ja) 2021-08-23 2022-08-23 肺疾患を処置及び予防するための組成物及び方法

Country Status (6)

Country Link
EP (1) EP4392052A4 (https=)
JP (1) JP2024532412A (https=)
KR (1) KR20240052799A (https=)
CN (1) CN118076372A (https=)
AU (1) AU2022332283A1 (https=)
CA (1) CA3175945A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017180546A1 (en) * 2016-04-11 2017-10-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
EP4132470A4 (en) * 2020-04-08 2023-11-08 Arizona Board of Regents on behalf of the University of Arizona COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASES

Also Published As

Publication number Publication date
AU2022332283A1 (en) 2024-03-07
CA3175945A1 (en) 2023-02-23
EP4392052A1 (en) 2024-07-03
CN118076372A (zh) 2024-05-24
EP4392052A4 (en) 2025-07-23
KR20240052799A (ko) 2024-04-23

Similar Documents

Publication Publication Date Title
US11110152B2 (en) Compositions and methods for treating and preventing lung disease
CN110201144B (zh) 用Nutlin-3a和肽抑制肺纤维化
US20230190861A1 (en) Peptide therapeutics for acute and chronic airway and alveolar diseases
JP7719590B2 (ja) Ｔｌｒアゴニストによる呼吸器感染症の治療
BR112021004420A2 (pt) formulação em pó seco de peptídeos de caveolina-1 e métodos de uso dos mesmos
CN112739367A (zh) Cav-1蛋白的修饰的肽片段及其在纤维化治疗中的用途
US20240082342A1 (en) Peptide therapeutics for increasing lung cell viability
US20240269242A1 (en) Compositions and methods for treating and preventing lung disease
JP7783830B2 (ja) 肺疾患を治療及び予防するための組成物及び方法
JP2024532412A (ja) 肺疾患を処置及び予防するための組成物及び方法
WO2023028491A1 (en) Compositions and methods for treating and preventing lung disease
US20210379141A1 (en) Compositions and methods for treating and preventing lung disease
JP2012505207A (ja) 慢性閉塞性肺疾患の予防用または治療用の薬剤組成物
JP2024539242A (ja) 慢性腎疾患の治療のための改変カベオリン－１ペプチド
US12551533B2 (en) Intranasal neuropeptides for use in stress-related impairments
US12173061B2 (en) Compositions and methods for treatment of chronic lung diseases
US20250144205A1 (en) Compositions and methods for treating infectious diseases
EP3113786B1 (en) Attenuation of intrapulmonary inflammation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250821

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250821